Results
Of 484 patients, 97.3% identified as White. Mean age was 45.8 years (SD 13.7) with a bimodal distribution (peaks: 32.5, 56.5). Patients were 46% premenopausal and 50% post-menopausal, with 103 patients previously receiving HRT. A full demographics table is included in Table 1 .
Demographic and survey data on included patients.
Female Sexual Distress Survey Revised decreased with increasing age (Spearman r = −0.124, P = .0072). Age-stratified analysis revealed a significant difference between age group and severity of distress, with women ≤40 years experiencing a higher frequency of scores >30 (OR: 1.765, 95% CI 1.200 to 2.563, P = .0030). Women aged 40 or younger had a median FSDS-R score of 31 (IQR 23-38), while women over age 40 had a median score of 28 (IQR 19-36, P = .0086). Of women ages 18-40, 51.67% ( n = 93) were classified as having severe-range (>30) sexual distress scores on the FSDS-R, compared to 37.72% ( n = 109) of women over 40 ( Figure 1 ).
Percent of patients age ≤40 and younger or >40 by severity of FSDS-R score indicating a higher percentage of younger women with severe distress, and a higher percentage of older women with no distress.
Female Sexual Distress Survey Revised data were missing for 15 patients, thus excluding them from analysis. Those 15 patients did not differ from the analyzed sample size in age ( P = .365) or diagnoses including dyspareunia ( P = .6016), GSM ( P = .6072), depression ( P = .6046), or anxiety ( P = .6109). Presence of HSDD did differ between the groups ( P = .0339) with 33.3% ( n = 5) of excluded patients diagnosed, versus 61.4% ( n = 288) of included patients diagnosed. Median FSDS-R score was 28 (IQR 21-37), and 420 (89.6%) patients met criteria for clinically impactful sexual distress (FSDS-R > 12). FSDS-R scores were not significantly related to menopausal status ( P = .068) or history of hysterectomy ( P = .32). Additionally, previous use of HRT was not associated with change in FSDS-R scores ( P = .20).
Female Sexual Function Index score was documented for 474 patients, with a median score of 15 (IQR 7.2-20.4). Previous use of HRT was associated with a lower total FSFI score ( P = .021). A weak negative correlation was noted between FSFI and age ( r = −0.18, CI −0.27 to −0.09, P < .001), with lower FSFI scores observed at higher ages. Univariate analysis showed lower FSFI scores associated with post-menopausal status ( P < .001), dyspareunia ( P = .0014), and GSM ( P < .001).
Of the patients analyzed ( n = 469), the most frequent genitourinary diagnoses included HSDD ( n = 288, 61.41%), dyspareunia ( n = 235, 50.11%), and GSM ( n = 215, 45.84%). Anxiety ( n = 222, 47.33%) and depression ( n = 228, 48.61%) represented the most frequent psychiatric diagnoses. Table 2 presents the diagnoses analyzed and the P -values from Mann–Whitney U tests comparing FSDS-R scores in patients with versus without each diagnosis.
Results of Mann–Whitney U test comparing the presence or absence of diagnosis and FSDS-R scores.
* Indicates diagnoses that met statistical significance after FDR correction ( * P ≤ .05; ** P ≤ .01; *** P ≤ .001).
Indicates grouped diagnosis. See Appendix A for the full list.
Premenstrual syndrome/premenstrual dysphoric disorder.
On univariate analysis, dyspareunia was not associated with a significant increase in FSDS-R score ( P = .368). Hypoactive sexual desire disorder was significantly associated with increased distress ( P < .0001), and women under age 40 had statistically higher rates of HSDD diagnosis when compared to women over age 40 years (χ 2 :8.79, P = .003). Diagnoses of uterine leiomyomas ( P < .001) and vulvovaginal irritation ( n = 16, P = .0061) showed significantly lower scores on FSDS-R.
Among psychiatric diagnoses investigated, depression ( P < .001), anxiety ( P < .001), PTSD ( P < .001), and history of sexual abuse ( P = .0045) or history of other abuse ( P = .0053) showed significant correlation with increased FSDS-R scores.
After correcting for multiple comparisons using FDR adjustment, HSDD, depression, anxiety, PTSD, and history of sexual or other abuse remained significantly associated with higher sexual distress and uterine leiomyomas and vulvovaginal irritation were associated with lower sexual distress ( q ≤ 0.05). A bar chart of univariate results is included in Figure 2 .
Univariate analysis of average FSDS-R scores by diagnoses, indicating a statistically significant increase associated with diagnoses of anxiety, PTSD, depression, history of sexual and other abuse, and HSDD. Vulvovaginal irritation and uterine leiomyomas showed a significant decrease in FSDS-R scores.
A multivariable linear regression was used to examine FSDS-R scores in relation to diagnoses when controlling for other factors. History of other abuse was excluded due to collinearity with sexual abuse (84.6% collinearity, as 11 out of the 13 patients diagnosed with a history of other abuse were also diagnosed with a history of sexual abuse). The overall model was statistically significant ( F (9, 458) = 12.69, P < .001) and explained approximately 20% of the variance in FSDS-R scores ( R 2 = 0.20). Regression assumptions were met, including normality of residuals and absence of multicollinearity (all VIFs < 1.6).
When controlling for other factors, this model found HSDD, dyspareunia, history of sexual abuse, and FSFI total score as predictive factors for increased distress. Hypoactive sexual desire disorder was the strongest predictor ( β = 6.03, 95% CI 3.98-8.08, P < .001) with FSDS-R scores approximately 6 points higher than those without HSDD. Diagnosis of dyspareunia demonstrated a 2.65-point increase when controlling for other factors ( β = 2.65 95% CI 0.66 to 4.65, P = .0093). History of sexual abuse ( β = 4.10, P = .029) and FSFI total score ( β = −0.31, P < .0001) were also significantly correlated with increased FSDS-R scores. Lastly, age was a small but statistically significant factor, with older age associated with slightly lower distress ( β = −0.086, P = .044). A regression analysis table is included in Table 3 and visual representation of β coefficients is provided in Figure 3 .
Multilinear regression table with β coefficient, 95% confidence interval, and P -value for each element included.
A forest plot demonstrating the beta coefficients of multivariable regression demonstrating a statistically significant relationship between distress and age, dyspareunia, HSDD, history of sexual abuse, and FSFI, with a borderline relationship of PTSD to distress.
Other variables, including GSM ( P = .49), anxiety ( P = .32), and depression ( P = .86) were not statistically significant predictors in the adjusted model. However, PTSD demonstrated a borderline relationship, with those diagnosed experiencing a 5-point increase in FSDS-R score ( β = 5.340, 95% CI −0.02437 to 10.82, P = .051).
Materials
The study consisted of a single-center, retrospective chart review with cross-sectional analytic components at a local women’s sexual health clinic from January of 2019 to July of 2025. A total of 515 charts were reviewed with inclusion criteria of assigned-female-at-birth patients who completed either a FSDS-R or FSFI survey during their appointment. Data collected included age, race, ethnicity, sexual orientation, genitourinary diagnoses, and mental health conditions. Additional factors collected included menopausal status, use of hormone replacement therapy (HRT) prior to the appointment, hysterectomy status, and scores on the FSDS-R, FSFI, urinary distress index-6 (UDI-6), and SES. UDI-6 scores were excluded from analysis due to inconsistent scoring, and SES was not included in analysis due to collinearity with FSDS-R scores.
Chart reviews were conducted by three reviewers, with one verifying diagnoses across all charts. Of 515 patients, 31 were excluded due to missing or incorrect survey data, leaving 484 charts for analysis. Diagnoses were obtained from ICD-10 codes (genitourinary and psychiatric diagnoses) as well as from narrative physician documentation in notes from the sexual health visit (history of sexual abuse, history of physical abuse). Under physician oversight, individual diagnoses were categorized using standardized medical criteria. Groupings followed definitions set by the International Federation of Gynecology and Obstetrics (menstrual disorders), 20 the North American Menopause Society (GSM), 21 and the Diagnostic and Statistical Manual of Mental Disorders (mood and sexual disorders). 22 Diagnoses reflect both current and historical conditions. A complete mapping of combined diagnoses is included in Appendix A .
Female Sexual Distress Survey Revised and FSFI scores were collected and documented as continuous variables. Severity scales utilized were based on standardized validated cutoffs (>12 for FSDS-R; 12; moderate >20; severe >30), and utilized in age-stratified analysis. Multiple linear regression utilized FSDS-R as a continuous variable. Age at appointment was collected as a continuous variable and sub-stratified into a binary categorical variable comparing women ≤40 versus women >40 years. This specific age cutoff was chosen due to standard clinical milestones regarding shifts in reproductive hormones, societal expectations, and relational dynamics. Post-hoc evaluation of sample demographics confirmed a bimodal distribution that aligned with this threshold.
Sample size was determined by available retrospective data with no formal power calculation. Statistical analyses were performed using chi-square tests, Mann–Whitney U , Spearman correlation analyses, and multivariable linear regression. Data were shown to have a non-normal distribution, necessitating nonparametric testing. To account for multiple comparisons, the false discovery rate (FDR) method using the two-stage step-up method of Benjamini, Krieger, and Yekutieli was applied. Model assumptions in the multivariable linear regression were assessed via variance inflation factors (VIFs) and residual analyses.
A standard simultaneous multivariable regression approach was selected a priori to explore the independent predictive weight of each clinical domain when holding all other co-occurring conditions constant, rather than assuming a strict hierarchical or causal pathway. To rule out multi-collinearity, VIF thresholds were strictly monitored. All statistical analysis was conducted via GraphPad Prism, version 10.6.1, and a two-tailed P -value ≤.05 was considered statistically significant.
This study was approved by the Institutional Review Board of Sanford Health with a waiver of informed consent due to the retrospective nature of the study.
Discussion
These findings indicate a crucial relationship between psychological and physiological experiences in sexual distress. When examining adjusted effect sizes, HSDD emerged as the largest impact with a 6.03-point increase on FSDS-R scoring associated with diagnosis. As FSDS-R is scored on a 0-52 scale, this represents an 11.5% increase in distress score, while PTSD (5.4) and history of sexual abuse (4.1) each represent a 10.4% and 7.9% point increase respectively. While dyspareunia demonstrated a slightly less robust increase (2.65 points), it still equates to an approximately 5% higher FSDS-R score, emphasizing that physical pain independently compounds sexual distress, even when accounting for sexual function (FSFI) and psychiatric comorbidities. Though limitations exist surrounding generalizability (homogeneity in race and ethnicity, single-center study, missing sexual orientation data), these findings offer important insights into the interaction of mental health with physiological conditions regarding distress.
Hypoactive sexual desire disorder emerged as a primary independent driver of distress, associated with the largest increase in FSDS-R score of all diagnoses studied and acts as a bridge between biological and psychosocial domains. Aligned with the DCM, this diagnosis likely provides a key clinical framework in which distress emerges from a disconnection between biophysiological excitation and inhibition, and patient desires and expectations regarding libido and intercourse. 13 , 23 Neurobiologically, HSDD has been linked to reduce excitatory signaling across multiple hormones and neurotransmitters, 13 while psychologically it reflects cognitive, emotional, and interpersonal influences. This finding remained consistent, even when controlling for other factors, indicating that patient perceptions of desire can impact distress beyond what can be explained by comorbid psychological or physical diagnoses alone. Women of reproductive age (18-40) were significantly more likely to carry a diagnosis of HSDD than older women, likely reflecting a complex interaction of hormonal, relational, psychosocial, and life-stage factors. Additionally, sociocultural scripts and cultural perceptions of sexual experiences influenced by media and online platforms may impact distress rates in younger women, which should be explored further in future studies.
Although prior studies and univariate analyses showed associations between depression or anxiety and higher FSDS-R scores, neither remained an independent predictor in multivariable regression. 16 , 24 However, this attenuation of significance should not be misinterpreted as a true lack of association. Because formal multicollinearity diagnostics were stable (VIF < 1.6), this statistical shift reflects a clinical reality of shared variance. The psychological distress of anxiety and depression likely overlaps with the central inhibitory pathways of trauma history and the profound impact of HSDD. When these variables compete within a simultaneous model, the variance is preferentially absorbed by the strongest independent drivers.
Historically, depression has been shown to create distress in conjunction with relational and emotional difficulties, negative body image, poor self-esteem, and self-confidence. 3 , 25 Women with depression may process sexual cues differently, with experiences dominated by negative thoughts and dysfunctional beliefs. 26 These cognitive patterns may affect other experiences and diagnoses, creating a complex environment in which distinguishing direct effects of depression from related psychosocial factors is challenging. 27 Biological influences on sexual arousal, baseline depressive symptoms, and potential effects of antidepressant medications further complicate the clinical picture, making holistic treatment approaches essential. Despite an attenuation of significance, depression is likely still deeply relevant to the patient’s holistic experience, and its impact on sexual distress is fundamentally intertwined with functional declines and primary desire diagnoses.
The loss of significance regarding anxiety may reflect overlap with trauma-related factors, as anxiety may indirectly contribute to distress through hypervigilance or misinterpretation of autonomic arousal as threat. 15 , 16 Consistent with previous literature, univariate analysis demonstrates that PTSD, anxiety, and a history of sexual abuse are associated with higher FSDS-R scores. 15 , 28 In patients who have experienced childhood sexual abuse, both FSDS-R and FSFI scores have reflected adverse changes. 29 The relationship between trauma, anxiety, and sexual response is complex and multifaceted. When considering why patients with a trauma history report higher distress or lower libido, clinicians should recognize that low desire often functions as a normal, adaptive form of self-protection rather than a pathology. Therefore, a critical first step in clinical care is explicitly validating and normalizing this lack of desire to the patient. From this foundation of safety, clinicians can then collaborate with patients to ensure conditions for adequate stimulation and relational security are met, ultimately promoting autonomy and satisfying sexual experiences. Additionally, genitopelvic pain has been linked to fear-avoidance cycles similar to PTSD, increasing avoidance behaviors and overall distress. 17 While anxiety’s impact on distress was attenuated on multivariable analysis, the interaction between trauma, psychological hypervigilance, and protective somatic boundaries remains profoundly influential, underscoring the importance of counseling and social support in promoting recovery and post-traumatic growth. 30
Regarding the impact of physiological diagnoses on distress, the association between dyspareunia and increased distress on multivariable regression in this study is consistent with previous studies. 19 The non-significance on univariate analysis suggests the impact of pain on sexual distress may be masked by other factors. Additionally, the finding that GSM was not significantly associated with an increase in distress represented an unexpected finding contrary to the hypothesis. This result may be accounted for by age as a protective factor (see “Age and Distress” subsection), or by the shifting socioculturally influenced expectations regarding sexual experiences that accompany increased age and menopausal status. Still, somatic pain represents an important, independent factor when evaluating sexual distress. Cognitive therapy and psychosocial support have previously shown to help women with genitourinary conditions experiencing distress, emphasizing the interplay of biological and psychological aspects of sexual experience. 17 , 25 , 31 , 32
Regarding the findings that vulvovaginal irritation and uterine leiomyomas appear to be protective against distress, this is likely due to limitations of small sample size ( n = 16 and n = 14, respectively). Additionally, the data collection tool did not indicate if conditions were current, historical, chronic, or acute. This lack of data on timing makes understanding the impact of these diagnoses on distress difficult. Moreover, the FSDS-R score only reflects a 1-month history of sexual distress, possibly limiting long-term impact of these conditions.
Consistent with previous literature, this study demonstrated that lower FSFI scores were strongly associated with higher distress and increased age. 5 , 11 However, despite this association, age emerged as a small protective factor toward distress in multivariable analysis. One explanation is a greater emotional resilience and stability among older women, potentially mitigating distress, 5 though this study showed no significant association between age group and diagnoses of depression or anxiety, suggesting this effect may not reach clinical significance. Another theory is differing expectations around sexual experiences and relationships between younger and older women. 5 Relational factors have proven to play an essential role regarding sexual experience, and the strength of long-term relationships associated with older age may play a role in alleviating distress. 1 , 25 In addition, this study found that previous use of HRT was associated with lower FSFI scores, which may be related to the association between lower FSFI scores and older age noted both in the study ( P < .001) and in previous literature. 11 In addition, because the FSFI survey includes factors such as arousal, pain, satisfaction, and desire, it is unclear in the current analysis if the lower scores were related to more physical or emotional factors.
In summary, these findings highlight the complex relationship between biological and psychosocial factors that drive sexual distress. While physical symptoms like dyspareunia and functional declines are significant, they must be considered in light of desire-based dysfunction (HSDD) and psychological trauma. This underscores the importance of screening female patients who present with sexual health concerns for both mental health conditions and trauma in addition to physical diagnoses. Treating physical symptoms alone in these patients may not be sufficient to reduce distress. Integrated care, multidisciplinary teams, and a highly individualized approach should be utilized.
This study has several limitations. First, participants were women presenting to a sexual health clinic and thus may have higher sexual distress than the general population. Despite efforts to reduce stigma around sexual and menopausal health, many women still do not recognize sexual dysfunction as treatable. 3 , 33 In this context, 89.6% of patients met the threshold for clinical distress, providing a unique perspective on women actively seeking care. Additionally, the 15 excluded patients with missing FSDS-R survey data had significantly lower diagnoses of HSDD ( P = .0339) and may introduce mild selection bias towards higher HSDD prevalence. However, given the small proportion of excluded patients, this selection bias is unlikely to meaningfully alter our primary findings.
The population was highly homogenous (97% White), limiting generalizability, and the sexual experiences of non-White patients remain understudied. 34 A substantial portion of patients had unknown sexual orientation, making it difficult to explore unique patterns in sexual minorities. This single-center review also warrants validation in larger, multicenter studies.
Finally, this study did not distinguish current versus historical diagnoses of conditions, nor did it account for treatment status, which may obscure associations with sexual distress. As some psychotropic medications can impact sexual function, future studies should include these as potential confounders.
Conclusions
Overall, these findings indicate that screening for mental health and trauma in addition to physical factors plays an essential role in treating patients experiencing sexual distress. While understanding the physiological impact of sexual dysfunction is essential to providing holistic treatment, the importance of integrating psychological support in these treatment plans cannot be understated. Care for patients experiencing sexual distress should consist of multidisciplinary teams, including mental health professionals, physical therapists, physicians specialized in women’s healthcare, and group support networks that promote therapeutic counseling in addition to medical management and physical treatment.
Introduction
Despite recent increases in female-centered health research, determinants of sexual distress remain underexplored while prevalence of sexual dysfunction varies greatly across studies. 1 Sexual distress is a multidimensional experience including psychosocial, physiological, and emotional aspects; however, many women experiencing sexual distress do not recognize their distress as treatable. 2 , 3 Additionally, the relationship between individual factors such as age, sexual function, and various physiologic and psychologic diagnoses remains ambiguous. 2 , 4 , 5
Historically, distress and its severity have been measured by validated surveys such as the Female Sexual Distress Survey Revised (FSDS-R). 6 , 7 Additionally, surveys such as the Female Sexual Function Index (FSFI) and the Sexual Experience Survey (SES) have been utilized to better understand female sexual experiences and sexual function. 8–10 While these measures provide a validated cutoff to determine clinical sexual dysfunction (FSFI 12), they do not explain why some women experience significant distress with dysfunction while others do not. Previous research has found that age-related declines in sexual function do not consistently translate to distress, with one study reporting that only 12% of patients with sexual dysfunction experience associated distress. 2 , 5 , 11
This raises questions as to the primary drivers of sexual distress. The Dual Control Model (DCM) merges cognitive experiences with neurophysical models to explain sexual distress. 12–14 According to the DCM, sexual response and its subsequent psychological appraisal rely on a delicate balance between central excitatory and inhibitory mechanisms. Within this framework, specific diagnoses can be understood as distinct disruptors of this balance.
Psychological trauma and post-traumatic stress disorder (PTSD) have been hypothesized to act as central inhibitors, as trauma induces autonomic hypervigilance and fear-avoidance cycles. 15 , 16 Conversely, primary desire-based pathology, like hypoactive sexual desire disorder (HSDD), represents an intrinsic disruption in excitatory signaling, driving emotional distress due to the conflict between a patient’s neurobiological baseline and her relational expectations. 13 Genitourinary conditions introduce direct somatic inhibitors via pain and structural tissue changes. This localized physical pain rapidly triggers cognitive distraction and anticipatory anxiety during intimacy, creating powerful feedback loops. 17–19 While the DCM strongly supports a holistic approach to sexual health, few clinical studies have simultaneously modeled these conditions to determine which exact biological or psychological conditions exert the strongest inhibitory thresholds on a patient’s emotional well-being.
By integrating validated measures across sexual function, distress, and trauma histories, the current study seeks to evaluate female sexual distress through three interconnected domains: biological factors (age, physiological diagnoses, menopausal status), psychological factors (depression, anxiety, history of trauma), and functional outcomes (FSFI scores). We hypothesized that primary desire-based pathology (HSDD), direct trauma (sexual abuse, PTSD), as well as physiologic factors that hinder function (such as genitourinary syndrome of menopause [GSM], dyspareunia) will emerge as primary drivers of higher FSDS-R scores.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.